US Stock MarketDetailed Quotes

SLRX Salarius Pharmaceuticals

Watchlist
  • 0.9531
  • +0.0572+6.38%
Close Mar 21 16:00 ET
  • 0.9202
  • -0.0329-3.45%
Post 20:01 ET
1.65MMarket Cap-0.19P/E (TTM)

Salarius Pharmaceuticals Key Stats

Salarius Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Salarius Pharmaceuticals Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More